In this part of the Duke-NUS Bio-Entrepreneur series, we will hear about the journey of Dr Sebastian Schaefer, Assistant Professor in Duke-NUS’ Cardiovascular and Metabolic Disorders programme. As a postdoctoral fellow, Dr Schaefer was a co-inventor for a technology that was spun out into a company, Enleofen. Dr Schaefer learned to be a successful entrepreneur on the fly. With assistance from the Duke-NUS Academic Medical Centre's (AMC’s) Joint Centre for Technology and Development, Enleofen’s R&D programme was acquired by Boehringer Ingelheim. Dr Schaefer will share his story of navigating the road to bio-entrepreneurship while balancing academic research. We invite you to join us in this webinar to learn more about finding the “right partners” within the Singapore biotech ecosystem for a successful spin-off.
*Please note your registration details will be shared with the co-organizing partners of this webinar, for internal purposes only.